MCM
FATE icon

Moore Capital Management’s Fate Therapeutics FATE Stock Holding History

Moore Capital Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,993
Closed -$672K – 583
2022
Q3 		$672K Buy
+29,993
New +$867K 0.02% 426
2022
Q2 		– Sell
-22,943
Closed -$890K – 727
2022
Q1 		$890K Buy
+22,943
New +$888K 0.03% 437
2021
Q3 		– Sell
-25,000
Closed -$2.17M – 829
2021
Q2 		$2.17M Sell
25,000
-23,431
-48% -$1.89M 0.04% 450
2021
Q1 		$3.99M Sell
48,431
-31,129
-39% -$2.98M 0.08% 318
2020
Q4 		$7.23M Buy
79,560
+29,560
+59% +$1.84M 0.12% 175
2020
Q3 		$2M Hold
50,000
– – 0.05% 265
2020
Q2 		$1.72M Buy
50,000
+25,900
+107% +$772K 0.06% 197
2020
Q1 		$535K Buy
+24,100
New +$609K 0.03% 139

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return